Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Fanfan, Pan"'
Publikováno v:
Endocrine Connections, Vol 13, Iss 12, Pp 1-8 (2024)
Background: Signal transducer and activator of transcription 6 (STAT6) is an important nuclear transcription factor. Previous studies demonstrated that blocking STAT6 can ameliorate thyroid function by reducing serum T3 and T4. Sodium/iodide symporte
Externí odkaz:
https://doaj.org/article/057b6a016e49428e8f85e9bc44f6fc60
Publikováno v:
In Safety Science March 2025 183
Publikováno v:
Endocrine Connections, Vol 12, Iss 2, Pp 1-8 (2023)
Objective: Neutropenia is a complication of Graves' disease (GD), but there is currently no means by which to predict its occurrence. This study aimed to investigate the risk factors for the development of neutropenia in untreated GD. Methods: This w
Externí odkaz:
https://doaj.org/article/57aa878f4fa744628e0d1f7540d20452
Publikováno v:
Archives of Endocrinology and Metabolism, Vol 67, Iss 1, Pp 55-63 (2022)
ABSTRACT Objective: MCM3AP-AS1 has been characterized as an oncogenic long non-coding RNA (lncRNA) in several cancers including papillary thyroid cancer (PTC), but its role in PTC has not been fully elucidated. Considering the critical role of lncRNA
Externí odkaz:
https://doaj.org/article/ae2b761aba364d98a33ab1b7d9a24b28
Publikováno v:
Environmental Policy and Governance.
Autor:
Rui, Nian, Wanjun, Li, Xiang, Li, Jiayu, Zhang, Weihua, Li, Fanfan, Pan, Jing, Cheng, Xin, Jin
Publikováno v:
Archives of endocrinology and metabolism.
Paired tumor and non-tumor tissues were collected from 63 papillary thyroid carcinoma (PTC) patients. Expression levels of
Publikováno v:
Endocrine connections.
Neutropenia is a complication of Graves' disease (GD) but there is currently no means by which to predict its occurrence. This study aimed to investigate the risk factors for development of neutropenia in untreated GD.This was a retrospective cohort
Autor:
Kai Wang1, Qinnan Zhang1, Panpan Zhang1, Qian Yang1, Fanfan Pan1, Bingbing Zha1 bingbingzha@fudan.edu.cn
Publikováno v:
Science Advances. 8/2/2024, Vol. 10 Issue 31, p1-8. 8p.